Table 1.

Clinicopathologic features of patients with NSCLCs included in the study

PatientHistologyAnatomic siteaStageRecurrenceAdjuvant chemotherapyGender/age, ySmoking statusbPack-yearsYears quit smokingcMonths to inclusion from surgeryd
1ADCLULIIAYesNoMale/81Former10012.01
2ADCRLLIBNoNoMale/64Former2719.15
3ADCRULIBYesYesMale/58Former1225.57
4SCCRLLIBYesYesFemale/62Former607.67
5ADCRLLIANoNoFemale/60Former3111.86
6ADCLLLIAYesYesMale/62Former405.85
7ADCRULIBYesYesMale/61Current70NA10
8SCCLULIBNoNoMale/64Current100NA5
9ADCRULIANoNoMale/69Former1236.58
10ADCRULIBNoNoFemale/63Former188.65
11ADCRULIBYesNoFemale/53Former425.83
12SCCRULIANoNoMale/62Former680.45
13SCCLULIANoNoMale/70Former961.47
14ADCLULIAYesYesFemale/45Former12.50.912
15ADCRLLIANoNoFemale/57Current80NA4
16ADCLLLIANoNoMale/65Former4821.07
17ADCLLLIANoNoMale/64Former925.17
18ADCRMLIBNoNoMale/71Former1022.32
19ADCLULIANoNoFemale/66Former5018.55

Abbreviations: ADC, adenocarcinoma; LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; SCC, squamous cell carcinoma.

  • aLocation of primary tumor in the lung.

  • bSmoking status at time of inclusion into the study (patient 7 quit smoking during the course of the study).

  • cYears from smoking cessation to time of inclusion into the study.

  • dMonths elapsed from surgery to time of inclusion into the study/first bronchoscopy time point.